These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3958271)

  • 1. How well do physicians recognize melanoma and other problem lesions?
    Cassileth BR; Clark WH; Lusk EJ; Frederick BE; Thompson CJ; Walsh WP
    J Am Acad Dermatol; 1986 Apr; 14(4):555-60. PubMed ID: 3958271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of dermatologists' and nondermatologists' diagnostic accuracy for malignant melanoma.
    Corbo MD; Vender R; Wismer J
    J Cutan Med Surg; 2012; 16(4):272-80. PubMed ID: 22784521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessment of a general practitioner training campaign for early detection of cutaneous melanoma in the Haut-Rhin department of France].
    Grange F; Hédelin G; Halna JM; Grall JC; Kirstetter H; Guillaume JC; Michel C
    Ann Dermatol Venereol; 2005 Dec; 132(12 Pt 1):956-61. PubMed ID: 16446636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight of decision-making impairs clinical assessment of melanocytic lesions.
    Gächter T; Mühleisen B; Schärer L; Dummer R; Burg G; Hofbauer GF
    J Cutan Med Surg; 2007; 11(1):9-18. PubMed ID: 17274934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer algorithms show potential for improving dermatologists' accuracy to diagnose cutaneous melanoma: Results of the International Skin Imaging Collaboration 2017.
    Marchetti MA; Liopyris K; Dusza SW; Codella NCF; Gutman DA; Helba B; Kalloo A; Halpern AC;
    J Am Acad Dermatol; 2020 Mar; 82(3):622-627. PubMed ID: 31306724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of HMB-45 monoclonal antibody uptake on various benign and malignant melanocytic lesions].
    Lampert A; Thomine E; Lauret P; Hemet J
    Ann Pathol; 1993; 13(2):100-7. PubMed ID: 8363667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histologic mimics of malignant melanoma.
    Bsirini C; Smoller BR
    Singapore Med J; 2018 Nov; 59(11):602-607. PubMed ID: 29774360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multicenter Survey: How Do Transplant Dermatologists Monitor Organ Transplant Recipients With Nevi?
    Özcan D; Seçkin D; Haberal M
    Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):198-202. PubMed ID: 29528027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the diagnosis of pigmented tumors of the skin and factors leading to a decision to excise. Dermatologists of the Postgraduate Association of Haute-Normandie].
    Collas H; Delbarre M; De Preville PA; Courville P; Neveu C; Dompmartin A; Balguerie X; Lemaistre B; Rzeznik JC; Thiebot B; Boullie MC; Bravard P; Michel Y; Krug M; Le Corvaisier-Pieto C; Young P; Thomine E; Boivin C; Ziade J; Pellerin A; Hellot MF; Leroy D; Lauret P; Benichou J; Joly P
    Ann Dermatol Venereol; 1999; 126(6-7):494-500. PubMed ID: 10495858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma trainer using simulated back skin: an innovative design.
    MacGregor CA; O'Donnell MK; Haley AC; Martini M; Robinson JK; Vozenilek JA
    Simul Healthc; 2012 Aug; 7(4):251-4. PubMed ID: 22678225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical spectrum of pigmented lesions.
    Schaffer JV; Bolognia JL
    Clin Plast Surg; 2000 Jul; 27(3):391-408, viii. PubMed ID: 10941560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
    Skender-Kalnenas TM; English DR; Heenan PJ
    J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between melanocytic nevi and malignant melanoma.
    Friedman RJ; Rigel DS; Heilman ER
    Dermatol Clin; 1988 Apr; 6(2):249-56. PubMed ID: 3378371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary care physicians as gatekeepers in managed care. Primary care physicians' and dermatologists' skills at secondary prevention of skin cancer.
    Gerbert B; Maurer T; Berger T; Pantilat S; McPhee SJ; Wolff M; Bronstone A; Caspers N
    Arch Dermatol; 1996 Sep; 132(9):1030-8. PubMed ID: 8795541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rational clinical examination. Does this patient have a mole or a melanoma?
    Whited JD; Grichnik JM
    JAMA; 1998 Mar; 279(9):696-701. PubMed ID: 9496989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Who removes pigmented skin lesions?
    Marks R; Jolley D; McCormack C; Dorevitch AP
    J Am Acad Dermatol; 1997 May; 36(5 Pt 1):721-6. PubMed ID: 9146533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant melanocytic lesions in infancy, childhood, and adolescence.
    Hoss DM; Grant-Kels JM
    Dermatol Clin; 1986 Jan; 4(1):29-44. PubMed ID: 3521978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic yield of histologic examination of seborrheic keratoses.
    Eads TJ; Hood AF; Chuang TY; Faust HB; Farmer ER
    Arch Dermatol; 1997 Nov; 133(11):1417-20. PubMed ID: 9371026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic ability of general practitioners and dermatologists in discriminating pigmented skin lesions.
    Brochez L; Verhaeghe E; Bleyen L; Naeyaert JM
    J Am Acad Dermatol; 2001 Jun; 44(6):979-86. PubMed ID: 11369910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of the value of the seven-point checklist in distinguishing benign pigmented lesions from melanoma.
    Keefe M; Dick DC; Wakeel RA
    Clin Exp Dermatol; 1990 May; 15(3):167-71. PubMed ID: 2142028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.